Kenneth Francis Hofland

ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)

Brian O’Neill, S M Griffin, C. Mariette et al. · BMC Cancer · 2017 · 156 citations · Full text

The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2

Mikkel Christian Alanin, Camilla Klausen, Per Cayé‐Thomasen et al. · European Archives of Oto-Rhino-Laryngology · 2014 · 55 citations

Neuro-oncology, Medicine, Vestibular Schwannoma +6

Dexrazoxane Protects against Myelosuppression from the DNA Cleavage–Enhancing Drugs Etoposide and Daunorubicin but not Doxorubicin

Kenneth Francis Hofland, Annemette Thougaard, Maxwell Sehested et al. · Clinical Cancer Research · 2005 · 44 citations · Full text

The European Medicines Agency Review of Eribulin for the Treatment of Patients with Locally Advanced or Metastatic Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Elias Péan, Sigrid Klaar, Eva Gil Berglund et al. · Clinical Cancer Research · 2012 · 38 citations

Breast Oncology, Cancer Management, Pharmacotherapy +16

Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide

Peter Buhl Jensen, Maxwell Sehested, Kenneth Francis Hofland et al. · Cancer Chemotherapy and Pharmacology · 2003 · 34 citations

Oncology, Medicine, Rescue Agent +10